Career Point: Bolstering The Pharma Industry With All-Encompassing Recruitment Excellence

Deepti Nandy, Head - Pharma TA & Operation

Deepti Nandy

Head - Pharma TA & Operation

The paradigm of recruitment and hiring within the pharmaceutical industry has undergone a significant transformation over the years, marked by notable shifts in candidate empowerment, the fostering of high-performance cultures, and the customization of work experiences. Notably, the transition to digitalization across the entire recruitment process, from sourcing to onboarding, marks a pivotal shift affecting various sectors, not exclusive to pharma. This digital evolution has empowered candidates, rendering them more accessible for interviews, thus altering the dynamics of candidate engagement. Moreover, the emphasis on cultivating a high-performance culture has intensified, prompting individuals to prioritize health and agility, fostering continuous learning and cross-functional collaboration. Furthermore, emerging trends indicate a heightened focus on specialized skill sets, particularly in areas like IT, Artificial Intelligence, cybersecurity, and digital marketing, indicating evolving job requirements in the pharmaceutical industry and beyond.

However, challenges persist including talent scarcity, high attrition, and strict hiring criteria, posing significant recruitment hurdles in the pharmaceutical industry. Significant talent shortage prevails due to rigid eligibility criteria, such as specific educational backgrounds required for positions in the pharmaceutical industry. Stringent requirements set by companies, including age groups and industry specialization, further limit the available talent pool. The decline in hiring fresh graduates exacerbates this shortage, while high attrition rates add to the challenge. Additionally, the cost of recruitment remains high due to investments in consultants and internal referral programs.

To this end, Career Point stands as a formidable player in the pharma recruitment industry, boasting over 25 years of expertise, instilling trust and credibility among clients and candidates alike. With a steadfast commitment to quality and customization, Career Point prioritizes a customer-centric approach, ensuring precise alignment with client needs. Ethical practices underscore every interaction, reinforcing its reputation for reliability and integrity. Leveraging seasoned leadership and strategic partnerships with pharmaceutical organizations, Career Point extends its reach and attracts top-tier talent.

Career point stands as a formidable player in the pharma recruitment industry, boasting over 25 years of expertise, instilling trust & credibility among clients & candidates alike

Deepti Nandy, Head - Pharma TA & Operation

Driving Diversity & Growth

One of the noteworthy milestones of the firm is its emphasis on staff growth and diversity. With a blend of experienced professionals who have grown within the firm and a focus on nurturing fresh talent, Career Point has cultivated a dynamic workforce. Notably, the firm boasts a workforce where women make up over 70 percent, surpassing industry benchmarks and contributing to a diverse and inclusive workplace culture.

In driving forward its commitment to diversity and staff growth, Career Point places a particular emphasis on the invaluable contributions of women within its workforce. With a steadfast dedication to nurturing talent and fostering an inclusive environment, the firm proudly champions the role of women at every level of its operations.

Women serve as not only integral members of the team but also as prominent leaders and decision-makers within the organization. Their diverse perspectives, innovative thinking, and dedication to excellence have played a pivotal role in shaping the firm's success story. By fostering a workplace culture where women are not only supported but also celebrated, Career Point continues to set the standard for excellence in the industry while driving positive change within the broader professional landscape.

Leading-edge Solutions for Diverse Pharmaceutical Recruitment Needs

Career Point's specialized talent acquisition team is uniquely positioned to address the diverse recruitment needs of pharmaceutical clients. With an industry-specific focus, this team is trained to understand the nuanced requirements of the pharmaceutical sector, which often includes multiple divisions with distinct needs. Every wing of Pharmaceutical/ Healthcare Industry, whether it is Phrama Formulation, Medical Device/Equipment or Diagnostics, presents its own set of challenges and requirements. Therefore, having a specialized recruitment team with an in-depth understanding of these divisions is essential. The firm’s talent acquisition team emphasizes the importance of tailoring recruitment strategies to meet the unique needs of each division, ensuring that clients receive candidates who are well-suited to their specific requirements.

The Talent acquisition team at Career Point operates with a proactive approach, utilizing a combination of talent scouting and internal headhunting to identify and attract top talent. The database created by Career Point over the course of 25 years in the pharmaceutical recruitment industry indeed stands out as a formidable asset. Its robustness and exclusivity set it apart from competitors, making it a distinctive advantage. The firm ensures that clients have access to a diverse pool of candidates who possess the skills and experience necessary to excel in their roles. Moreover, the Talent acquisition team places a strong emphasis on fitment, recognizing that a successful recruitment process goes beyond simply matching qualifications to job requirements. By focusing on cultural fit and alignment with organizational objectives, the firm ensures that clients receive candidates who are not only qualified but also well-suited to their organizational culture and values.

In instances where clients have bulk hiring needs that must be filled urgently, Career Point offers Turnkey Staffing and Recruitment Process Outsourcing (RPO) services. These services are designed to provide clients with a comprehensive solution for their recruitment needs, allowing them to quickly scale their workforce while maintaining quality and efficiency. The Turnkey Staffing and RPO services offered by the firm are backed by a team of experienced recruiters who are well-versed in handling large-scale recruitment projects. By leveraging their expertise and industry insights, the firm is able to effectively meet the immediate hiring needs of pharmaceutical clients, ensuring that they have access to the talent they need to drive success.

Furthermore, Career Point's client engagement process is characterized by a comprehensive approach that begins with a thorough understanding of client requirements. By engaging with hiring managers and stakeholders, the firm ensures that it has a clear understanding of client expectations and objectives. This information is then used to develop tailored recruitment strategies and checklists, ensuring that candidates are sourced and screened according to client specifications. Throughout the recruitment process, it maintains open lines of communication with clients, soliciting feedback and making adjustments as needed to ensure a successful outcome. By continuously striving for improvement and innovation, the firm ensures the delivery of high-quality recruitment services that meet the evolving needs of pharmaceutical clients.

“The major factors that distinguish us from other players in the industry stem from our unique outlook and specialized approach. We lay our emphasis on tailored solutions and expertise, particularly in recruitment, where specialized recruiters focus solely on specific segments within the pharmaceutical industry. This specialization ensures a deep understanding of each role's requirements, leading to zero rejection rates and streamlined candidate sourcing”, adds Deepti Nandy, Head - Pharma TA & Operation at Career Point.

Journey of Excellence in Pharmaceutical Recruitment

Since its inception in 1999, Career Point has achieved significant milestones, including celebrating its 25th year of operation, marking a quarter-century of service in the pharmaceutical, healthcare, and medical device industries. Operating nationwide and extending services to neighboring countries like Nepal, Bangladesh, and Sri Lanka, underscores its regional reach. Additionally, the firm's evolution from traditional sourcing to comprehensive talent acquisition support reflects its adaptability and commitment to meeting clients' evolving needs.

Looking ahead, the future roadmap of Career Point encompasses a blend of upskilling, strategic operations, and digital transformation to adapt to evolving industry demands. With a focus on continuous upskilling and reskilling, the firm emphasizes the importance of staying abreast of industry requirements. Key innovations include leveraging AI for automated candidate assessments and enhancing virtual interview capabilities. Personalized experiences and support are prioritized, alongside a commitment to diversity and inclusion initiatives. By embracing technology, personalization, and diversity, Career Point charts a progressive course in the pharmaceutical recruitment landscape.

"With 25 years of experience in pharmaceutical recruitment since our inception in 1999, we've consistently adapted to industry changes. Ethical conduct towards candidates and companies remains our priority, fostering credibility and performance. Upholding integrity, we ensure candidates and companies receive ethical treatment, driving excellence in our operations", concludes Subhasish Nandy, Consulting Partner at Career Point.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.